跳至主要内容
临床试验/JPRN-C000000422
JPRN-C000000422已完成4 期

Randomized double blind comparative study of nipradilol, an alfa-1,beta-blocker with a nitric oxide donative action, and timolol, a non-selective beta-blocker, on the visual field in Japanese patients with normal-tension glaucoma. - Japanese Normal Tension Glaucoma Treatment Study (JNTGTS)

KOWA company, ltd.0 个研究点目标入组 150 人开始时间: 2006年5月25日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
入组人数
150

研究概览

简要总结

The effect of topical nipradilol and timolol on progression of visual field damage and IOP was found to be equivalent in Japanese NTG patients whose untreated IOP was 14mmHg.

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 60years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • Patients with -Cataract which affects the visual field or corrected vision of <0.8 -Refraction of <-0.8D or >5.0D -A history of invasive eye surgery -Complication with serious retinal disease that affects the visual field -Complications which require treatment using the following prohibited drugs: i.e., drugs that influence intraocular pressure or blood flow, and drugs that have neuroprotective action -Complication with diabetes mellitus -Pulse rate of 50/min or less -Routine systolic blood pressure of 110 mmHg or below -Patients who are pregnant, nursing or are suspected of being pregnant

研究者

相似试验

Randomized double blind comparative study of... | 临床试验